Equity Profile

DGX

Quest Diagnostics Incorporated

Health CareHealth Care Services$22.2B

Jul21Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic information services, offering a wide range of laboratory testing and related services. As a key player in the health care sector, it plays an essential role in disease detection, management, and prevention, which is increasingly important as health care demands rise.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability and will indicate how well the company has performed compared to previous quarters.

N/A

Revenue Growth

Revenue growth will provide insight into the company's ability to expand its services and capture market share in the health care sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DGX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.79%

Avg Stock Reaction

+3.85%

Last Quarter Recap

In Q1-2026, Quest Diagnostics reported an EPS of $2.50, exceeding expectations by 5.44%. The stock reacted positively, gaining 4.45% the next day, reflecting strong investor confidence.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, the market is cautiously optimistic about Quest Diagnostics' upcoming earnings, especially given its history of beating EPS estimates.

Bull Case

If the company continues its trend of beating EPS estimates, it could see significant stock price appreciation, especially if revenue growth is also strong.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a negative reaction from investors.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's strong track record of beating EPS estimates, this number will be crucial in determining market sentiment.

How is revenue growth trending compared to previous quarters?

Revenue growth is a key indicator of the company's ability to expand its market presence and maintain profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Quest Diagnostics' ability to leverage its diagnostic services for growth, especially in light of increasing health care demands.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational execution.

Options pricing suggests a lower expected move than historical averages, indicating potential for a surprise.

The lack of recent peer reports may lead to an underappreciation of Quest's unique market position.

Key Risk

If the EPS comes in below $2.40, it could significantly undermine the bullish narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Quest Diagnostics can maintain its growth trajectory and profitability in a competitive health care landscape.

Bull Confirmed If

An EPS of $2.55 or higher would confirm the bull case, indicating continued strong performance.

Bear Confirmed If

An EPS below $2.40 would support the bear case, suggesting potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±2.31%

Historical Avg

±5.7%

Pricing cheap

The options market is pricing in a modest move of about 2.31%, suggesting that traders expect limited volatility around the earnings announcement.

Options are pricing ±2.3% while DGX has averaged ±5.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

24.2%

Calls (31K)P/C Ratio: 0.25Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Quest Diagnostics beats expectations, history suggests the stock could rise by around 3.85%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may see muted movement as investors reassess future growth.

Miss

Should the company miss expectations, history suggests a potential decline of around 3.85%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new diagnostic services or technologies being introduced.
2Insights into how the company is managing costs amidst rising health care demands.
3Comments on competitive pressures in the diagnostic services market.
4Updates on partnerships or collaborations that could enhance service offerings.
5Management's outlook on future revenue growth and market conditions.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

ICICI Bank Limited

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability and will indicate how well the company has performed compared to previous quarters.

N/A

Revenue Growth

Revenue growth will provide insight into the company's ability to expand its services and capture market share in the health care sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DGX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.79%

Avg Stock Reaction

+3.85%

Last Quarter Recap

In Q1-2026, Quest Diagnostics reported an EPS of $2.50, exceeding expectations by 5.44%. The stock reacted positively, gaining 4.45% the next day, reflecting strong investor confidence.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, the market is cautiously optimistic about Quest Diagnostics' upcoming earnings, especially given its history of beating EPS estimates.

Bull Case

If the company continues its trend of beating EPS estimates, it could see significant stock price appreciation, especially if revenue growth is also strong.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a negative reaction from investors.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's strong track record of beating EPS estimates, this number will be crucial in determining market sentiment.

How is revenue growth trending compared to previous quarters?

Revenue growth is a key indicator of the company's ability to expand its market presence and maintain profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Quest Diagnostics' ability to leverage its diagnostic services for growth, especially in light of increasing health care demands.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational execution.

Options pricing suggests a lower expected move than historical averages, indicating potential for a surprise.

The lack of recent peer reports may lead to an underappreciation of Quest's unique market position.

Key Risk

If the EPS comes in below $2.40, it could significantly undermine the bullish narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Quest Diagnostics can maintain its growth trajectory and profitability in a competitive health care landscape.

Bull Confirmed If

An EPS of $2.55 or higher would confirm the bull case, indicating continued strong performance.

Bear Confirmed If

An EPS below $2.40 would support the bear case, suggesting potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±2.31%

Historical Avg

±5.7%

Pricing cheap

The options market is pricing in a modest move of about 2.31%, suggesting that traders expect limited volatility around the earnings announcement.

Options are pricing ±2.3% while DGX has averaged ±5.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

24.2%

Calls (31K)P/C Ratio: 0.25Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Quest Diagnostics beats expectations, history suggests the stock could rise by around 3.85%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may see muted movement as investors reassess future growth.

Miss

Should the company miss expectations, history suggests a potential decline of around 3.85%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new diagnostic services or technologies being introduced.
2Insights into how the company is managing costs amidst rising health care demands.
3Comments on competitive pressures in the diagnostic services market.
4Updates on partnerships or collaborations that could enhance service offerings.
5Management's outlook on future revenue growth and market conditions.